152 Results found for "luf research"
-
Transparent screening makes for better matches
Job seekers are increasingly likely to undergo pre-employment screening such as a criminal record check. The big question is what tools are used and how is the information acquired assessed?
-
Committees
LUF has three of its own spending committees: the Committee for Academic Expenditure (CWB), the LUF International Study Fund Committee (LISF), the Committee on General Grants for Student Activities Grants (CASSA).
-
[pdf] jaarverslag-2014-pdf
-
General
LUF International Studie Fund (LISF)
-
Research into better treatment for inflammation of the brain
The effects of encephalitis, inflammation of the brain, are varied but have a huge impact. With the aid of the LUF, Dr Jutte de Vries, a medical microbiologist at the LUMC, is working on a solution.
-
Leiden Empowerment Fund 2021
The aim of the Leiden Empowerment Fund (LEF) is to enable all students and academics at Leiden University to realise their ambitions by creating an academic environment with equal opportunities for all.
-
The intestinal bacterium Ruminococcus gnavus: friend or foe?
People with chronic intestinal inflammation, such as Crohn's disease, often have high numbers of the gut bacterium Ruminococcus gnavus (R. gnavus) in their intestines. But why? To answer that question, LUMC researchers have for the first time mapped the complete genetic code (genome) of this bacterium on a large scale. And to accelerate further research on R. gnavus, they are offering all data for free to other researchers.
-
[pdf] luf_magazine-2024_def-online
-
The research of... Judith Kroep
Medical oncologist and researcher Judith Kroep conducts research into ovarian cancer. She received €70,000 for her research project from the Willemijn Charity Golf Day crowdfunding campaign on steunleiden.nl.
-
Targeted immunotherapy for cancer patients
Immunotherapy stimulates the cancer patient's own immune system to attack the cancer. However, this therapy is not effective in all patients. With a grant from the Nypels-Van der Zee Fund, Dr Noel de Miranda has developed a rapid, effective test to select suitable patients.
